Literature DB >> 22401957

Regulation of central noradrenergic activity by 5-HT(3) receptors located in the locus coeruleus of the rat.

Jorge E Ortega1, Aitziber Mendiguren, Joseba Pineda, J Javier Meana.   

Abstract

A functional interaction between serotonergic and noradrenergic systems has been shown in the locus coeruleus (LC). Noradrenaline (NA) levels in the prefrontal cortex (PFC) are dependent on the firing rate of LC neurons, which is controlled by α(2) adrenoceptors (α2ADR). The aim of the present study was to investigate the role of 5-HT(3) receptors (5HT3R) in the modulation of central noradrenergic activity. We measured extracellular NA concentrations in the LC and PFC by dual-probe microdialysis in awake rats and the firing rate of LC neurons by electrophysiological techniques in vitro. Administration of the 5HT3R agonists SR57227 (1-100 μM) and m-chlorophenylbiguanide (mCPBG, 1-100 μM) into the LC increased NA in this nucleus (E(max) = 675 ± 121% and E(max) = 5575 ± 1371%, respectively) and decreased NA in the PFC (E(max) = -49 ± 6% and E(max) = -25 ± 11%, respectively). Administration of the 5HT3R antagonist Y25130 (50 μM) into LC attenuated SR57227 effect in the LC (E(max) = 323 ± 28%) and PFC (E(max) = -37 ± 7%). The α2ADR antagonist RS79948 (1 μM) blocked the SR57227 effect in the PFC but it did not change the effect in the LC (E(max) = 677 ± 202%). In electrophysiological assays, both mCPBG (1-10 μM) and SR57227 (1-10 μM) reduced the firing rate of about 50% of tested LC neurons (maximal effect = -37 ± 2% and -31 ± 4%, respectively); this effect was partially blocked by Y25130 (50 μM). Administration of RS79948 (1 μM) reversed the inhibition induced by mCPBG. Competition radioligand assays against [(3)H]UK14304 and [(3)H]RX821002 (α2ADR selective drugs) in the rat brain cortex showed a very weak affinity of SR57227 for α2ADR, whereas the affinity of mCPBG for α2ADR was 17-fold higher than that of SR57227 for α2ADR. The present results suggest that 5HT3R stimulate NA release in the LC, which promotes simultaneously a decrease in the firing rate of LC neurons through α2ADR and then a decrease of NA release in terminal areas such as the PFC.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401957     DOI: 10.1016/j.neuropharm.2012.02.018

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study.

Authors:  Igor Horrillo; Jorge E Ortega; Rebeca Diez-Alarcia; Leyre Urigüen; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2016-09-04       Impact factor: 4.530

2.  Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain.

Authors:  Begoña Fernández-Pastor; Jorge E Ortega; J Javier Meana
Journal:  Psychopharmacology (Berl)       Date:  2013-05-02       Impact factor: 4.530

3.  Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease.

Authors:  Zheng Ye; Ellemarije Altena; Cristina Nombela; Charlotte R Housden; Helen Maxwell; Timothy Rittman; Chelan Huddleston; Charlotte L Rae; Ralf Regenthal; Barbara J Sahakian; Roger A Barker; Trevor W Robbins; James B Rowe
Journal:  Brain       Date:  2014-02-27       Impact factor: 13.501

4.  Ca(2+) in the dorsal raphe nucleus promotes wakefulness via endogenous sleep-wake regulating pathway in the rats.

Authors:  Su-Ying Cui; Sheng-Jie Li; Xiang-Yu Cui; Xue-Qiong Zhang; Bin Yu; Yuan-Li Huang; Qing Cao; Ya-Ping Xu; Guang Yang; Hui Ding; Jin-Zhi Song; Hui Ye; Zhao-Fu Sheng; Zi-Jun Wang; Yong-He Zhang
Journal:  Mol Brain       Date:  2016-07-26       Impact factor: 4.041

5.  Noradrenergic Components of Locomotor Recovery Induced by Intraspinal Grafting of the Embryonic Brainstem in Adult Paraplegic Rats.

Authors:  Anna Kwaśniewska; Krzysztof Miazga; Henryk Majczyński; Larry M Jordan; Małgorzata Zawadzka; Urszula Sławińska
Journal:  Int J Mol Sci       Date:  2020-08-01       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.